XASXEBR
Market cap224mUSD
Dec 19, Last price
0.99AUD
1D
14.53%
1Q
10.67%
IPO
53.91%
Name
EBR Systems Inc
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
-35m
L+5.89%
CFO
-33m
L+7.71%
Earnings
May 29, 2025
Profile
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system that uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart. Its products are used to eliminate lead complications, such as placement difficulty, unintended nerve stimulation, dislodgement, extraction, and repositioning. The company was incorporated in 2003 and is based in Sunnyvale, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | |||||
Cost of revenue | 29,414 | 26,743 | 17,186 | ||
Unusual Expense (Income) | |||||
NOPBT | (29,414) | (26,743) | (17,186) | ||
NOPBT Margin | |||||
Operating Taxes | 2 | 2 | 20,936 | ||
Tax Rate | |||||
NOPAT | (29,416) | (26,744) | (38,121) | ||
Net income | (35,037) 5.89% | (33,088) -16.94% | (39,835) 54.89% | ||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | 21,670 | 208 | 76,027 | ||
BB yield | -12.30% | ||||
| Debt | |||||
Debt current | 272 | 268 | 2,596 | ||
Long-term debt | 43,238 | 23,455 | 4,535 | ||
Deferred revenue | |||||
Other long-term liabilities | 77 | 482 | |||
Net debt | (29,930) | (40,792) | (71,111) | ||
| Cash flow | |||||
Cash from operating activities | (32,698) | (30,356) | |||
CAPEX | (354) | (730) | (912) | ||
Cash from investing activities | (8,641) | (49,348) | (907) | ||
Cash from financing activities | 40 | 17,014 | 95,757 | ||
FCF | (28,706) | (26,375) | (41,121) | ||
| Balance | |||||
Cash | 72,315 | 63,529 | 78,242 | ||
Long term investments | 1,126 | 986 | |||
Excess cash | 73,441 | 64,515 | 78,242 | ||
Stockholders' equity | 32,020 | 43,949 | 75,898 | ||
Invested Capital | 40,703 | 22,068 | 4,807 | ||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | 288,875 | 269,609 | 42 | ||
Price | 0.61 | ||||
Market cap | 176,214 | ||||
EV | 146,284 | ||||
EBITDA | (29,414) | (26,743) | (17,186) | ||
EV/EBITDA | |||||
Interest | 4,484 | 1,526 | 19,010 | ||
Interest/NOPBT | |||||